Contrato de Suministro (CONTR 2026 0000143167)
TED · 621777-2026Award noticeawardedNo deadline given
Value
Estimated€25,260,400 · 25,260,400 EUR
Awarded€12,630,200 · 12,630,200 EUR
WinnerNOVOCURE SPAIN
Who already wins at this buyer
Firms with recorded awards from Servicio Andaluz de Salud. Servicios Centrales in this tender’s CPV categories — the incumbents you are bidding against.
| Firm | Wins | Awarded | Last win |
|---|---|---|---|
| Sanofi Aventis, S.A. | 2 | €63,469,120 | 2026-07-08 |
| World Medica SLU | 2 | €35,589,830 | 2026-06-17 |
| PRIM SA | 2 | €11,067,365 | 2026-06-17 |
| Pfizer, S.L. | Glaxosmithkline, S.A. | 1 | €60,099,699 | 2026-06-02 |
| Merck Sharp & Dohme de España, S.A. | 1 | €23,025,600 | 2026-07-20 |
Full buyer profile: what Servicio Andaluz de Salud. Servicios Centrales buys and who wins it →
CPV codes
33140000 Medical equipment & pharmaceuticalsDescription
- Acuerdo Marco por el que se fijan las condiciones para el suministro de tracto sucesivo y precio unitario de dispositivos OPTUNE (TTFIELDS) de tratamiento para pacientes con glioblastoma de nuevo diagnóstico en los centros del Servicio Andaluz de Salud.